Th Am 2010, 4:1019-1039. Lalande JD, Behr MA: Mycobacteria in Crohn’s
Th Am 2010, 4:1019-1039. Lalande JD, Behr MA: Mycobacteria in Crohn’s disease: how innate immune deficiency may result in chronic inflammation. Expert Rev Clin Immunol 2010, 6:633-641. Marttila RJ, Arstila P, Nikoskelainen J, Halonen PE, Rinne UK: Viral antibodies in the sera from patients with Parkinson disease. Eur Neurol 1977, 15:25-33. Rott R, Herzog S, Fleischer B, Winokur A, Amsterdam J, Dyson W, Koprowski H: Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders. Science 1985, 228:755-756. Beaman BL: Bacteria and neurodegeneration. In Neurodegenerative Diseases Edited by: Caino DWB, Saunders, Orlando, FL 1994, 319-338. Miklossy J: Biology and neuropathology of dementia in syphilis and Lyme disease. In Dementias. Edited by: Duyckaerts C, Litvan I. Edinburgh, London, New York, Oxford, Philadelphia, St-Louis, Toronto, Sydney: Elsevier; 2008:825-844, Series Editor Aminoff MJ, Boller F, Schwab DS: Handbook of Clinical Neurology vol. 89. Salvatore M, Morzunov S, Schwemmle M, Lipkin WI: Borna disease virus in brains of North American and European people with schizophrenia and bipolar disorder. Chloroquine (diphosphate) cancer Lancet 1997, 349:1813-1814.Miklossy Journal of Neuroinflammation 2011, 8:90 http://www.jneuroinflammation.com/content/8/1/Page 13 of31. Langford D, Masliah E: The emerging role of infectious pathogens in neurodegenerative diseases. Exp Neurol 2003, 184:553-555. 32. Fischer O: Miliare Nekrosen mit drusigen Wucherungen der Neurofibrillen, eine regelm sige Ver derung der Hirnrinde bei seniler Demenz. Monatschr f Psychiat Neurol 1907, 22:361-372. 33. Alzheimer A: er eigenartige Krankheitsf le des sp eren Alters. Z Ges Neurol Psychiat 1911, 4:356-385. 34. Koch R: Die Aetiologie der Tuberculose. Mitt Kaiser Gesundh 1884, 2:1-88. 35. Koch R: Ueber den augenblicklichen Stand der bakteriologischen Cholera Diagnose. J Hyg Inf 1893, 14:319-333. 36. Hill AB: The environment and disease: Association or causation? Proceedings of the Royal Society of Medicine, Section of Occupational Medicine, Meeting January 1965, 14:295-300. 37. Alzheimer A: er eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiat Med 1907, 64:146-148. 38. Katzman R: The prevalence and malignancy of Alzheimer’s disease: a major killer. Arch Neurol 1976, 33:217-218. 39. Terry RD, PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/28878015 Davies P: Dementia of the Alzheimer type. Ann Rev Neurosci 1980, 3:77-95. 40. Bertram L, Tanzi RE: The genetic epidemiology of neurodegenerative disease. J Clin Invest 2005, 115:1449-1457. 41. Nagy Z: The last neuronal division: a unifying hypothesis for the pathogenesis of Alzheimer’s disease. J Cell Mol Med 2005, 9:531-541. 42. Tanzi RE, Vaula G, Romano DM, Mortilla M, Huang TL, Tupler RG, Wasco W, Hyman BT, Haines JL, Jenkins BJ, et al: Assessment of amyloid betaprotein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases. Am J Hum Genet 1992, 51:273-282. 43. Roses AD: Apolipoprotein E is a relevant susceptibility gene that affects the rate of expression of Alzheimer’s disease. Neurobiol Aging 1994, 2(Suppl):165-167. 44. McGeer PL, McGeer EG: Polymorphisms in inflammatory genes and the risk of Alzheimer disease. Arch Neurol 2001, 58:1790-1792. 45. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE: Systematic metaanalyses of Alzheimer PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/25645579 disease genetic association studies: the AlzGene database. Nat Genet 2007, 39:17-23. 46. Guo JP, Arai T, Miklossy J, McGeer PL: Abeta and tau form soluble complexes that may promote self aggregation of bo.
